FI863095A0 - Transmissibla daeggdjursgener associerade med tumoermetastaser. - Google Patents

Transmissibla daeggdjursgener associerade med tumoermetastaser.

Info

Publication number
FI863095A0
FI863095A0 FI863095A FI863095A FI863095A0 FI 863095 A0 FI863095 A0 FI 863095A0 FI 863095 A FI863095 A FI 863095A FI 863095 A FI863095 A FI 863095A FI 863095 A0 FI863095 A0 FI 863095A0
Authority
FI
Finland
Prior art keywords
tumoermetastaser
daeggdjursgener
associerade
transmissible
med
Prior art date
Application number
FI863095A
Other languages
English (en)
Finnish (fi)
Other versions
FI863095A7 (fi
FI863095L (fi
Inventor
Shelly C Bernstein
Robert A Weinberg
Original Assignee
Whitehead Biomedical Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Biomedical Inst filed Critical Whitehead Biomedical Inst
Publication of FI863095A7 publication Critical patent/FI863095A7/fi
Publication of FI863095L publication Critical patent/FI863095L/fi
Publication of FI863095A0 publication Critical patent/FI863095A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI863095A 1984-11-30 1985-11-26 Transmissibla daeggdjursgener associerade med tumoermetastaser. FI863095A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67662584A 1984-11-30 1984-11-30
PCT/US1985/002323 WO1986003226A1 (en) 1984-11-30 1985-11-26 Transmissible, mammalian genes associated with tumor metastasis

Publications (3)

Publication Number Publication Date
FI863095A7 FI863095A7 (fi) 1986-07-29
FI863095L FI863095L (fi) 1986-07-29
FI863095A0 true FI863095A0 (fi) 1986-07-29

Family

ID=24715276

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863095A FI863095A0 (fi) 1984-11-30 1985-11-26 Transmissibla daeggdjursgener associerade med tumoermetastaser.

Country Status (13)

Country Link
EP (1) EP0203970A1 (cs)
JP (1) JPS62501399A (cs)
AU (1) AU5197986A (cs)
DK (1) DK359486A (cs)
ES (1) ES8705043A1 (cs)
FI (1) FI863095A0 (cs)
GR (1) GR852864B (cs)
HU (1) HUT41837A (cs)
IL (1) IL77157A0 (cs)
NO (1) NO863066L (cs)
PT (1) PT81584B (cs)
WO (1) WO1986003226A1 (cs)
ZA (1) ZA859070B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
ES2164634T3 (es) * 1989-10-18 2002-03-01 Us Health Produccion y uso de proteina nm23-h2 humana y anticuerpos previstos a tal efecto.
US6825320B1 (en) 1995-03-29 2004-11-30 Millenium Pharmaceuticals, Inc. FOHY03 polypeptides
US6251597B1 (en) 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
US6794185B1 (en) 1995-03-29 2004-09-21 Millennium Pharmaceuticals, Inc. fohy030 nucleic acid molecules
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
US5783182A (en) * 1996-01-30 1998-07-21 Baylor College Of Medicine Method for identifying metastatic sequences
CA2237929A1 (en) * 1995-11-16 1997-05-22 Baylor College Of Medicine Method for identifying metastatic sequences
US6875429B1 (en) * 1996-01-10 2005-04-05 University Of Liverpool Metastasis inducing DNA's
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
EP1029048A2 (en) 1997-11-05 2000-08-23 Baylor College Of Medicine Sequences for targeting metastatic cells
EP1062340A2 (en) 1998-03-13 2000-12-27 The Baylor College of Medicine Compositions and methods for the treatment and prevention of metastatic disorders
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin

Also Published As

Publication number Publication date
FI863095A7 (fi) 1986-07-29
WO1986003226A1 (en) 1986-06-05
FI863095L (fi) 1986-07-29
ZA859070B (en) 1986-07-30
GR852864B (cs) 1986-03-28
NO863066D0 (no) 1986-07-29
AU5197986A (en) 1986-06-18
IL77157A0 (en) 1986-04-29
HUT41837A (en) 1987-05-28
DK359486D0 (da) 1986-07-29
JPS62501399A (ja) 1987-06-11
ES8705043A1 (es) 1987-04-16
EP0203970A1 (en) 1986-12-10
DK359486A (da) 1986-07-29
PT81584A (en) 1985-12-01
PT81584B (en) 1987-04-07
NO863066L (no) 1986-09-29
ES549438A0 (es) 1987-04-16

Similar Documents

Publication Publication Date Title
FI850694L (fi) Mellandestillatfoereningar med foerbaettrade kallrinningsegenskaper.
FI853315A0 (fi) Styranordning foer en foerbraenningsmotor med en avgasturbokompressor.
FI854891L (fi) Arkitektonisk belaeggning med interferensfaerger.
FI850386L (fi) Metalroer foersett med ytbelaeggning.
FI852042L (fi) Kaernmagnetisk resonansanordning med ytspoledetektering.
FI840828L (fi) Konditionsstaellning med stoed foer skivstaong.
FI850645A0 (fi) Olefinpolymerfibrer med laogt deniertal.
FI841689A0 (fi) Sjaelvtoemmande sopskyffel med laongt skaft.
FI860211A0 (fi) Svaevarkonstruktion med foerbaettrad manoeverbarhet.
FI863095A0 (fi) Transmissibla daeggdjursgener associerade med tumoermetastaser.
FI860563A0 (fi) Kompressorenhet med vaetskering.
FI853380L (fi) Apparatstickpropp med integrerat elektriskt avstoerningsfilter.
FI862788L (fi) Med vaermeaotervinningsanordning foersedd foerbraenningsanlaeggning foer avfallsvaetska.
FI843301A0 (fi) Drivanordning foersedd med motroterande propellrar.
FI861264L (fi) Aendtillslutning med inaot vikt flikfoerslutning.
FI854649A7 (fi) Tryckdifferens-maetanordning med en halvledartrycksensor.
FI850380A0 (fi) Staellverksskaop med beroeringsskyddat skensystem.
FI854154L (fi) Skidbyxor med elastiskt midjeband.
FI850721L (fi) Vakuumstyrsystem med prioritetsbestaemning.
FI853190A0 (fi) Videosignalbehandlingssystem med hoegfrekvenskompensation.
FI843235A0 (fi) Centrifugalvattenpump och -vattenkraftverk med lufttryckdrift.
FI844641A0 (fi) Foerpackningsanordning med flera avdelningar.
FI840368L (fi) Rising-film ltv-avdunstare med foerbaettrad vaermeoeverfoeringsmekanism.
FI843619A0 (fi) Ankare med boejliga ankarflyn.
FI842649A0 (fi) Propelleraxel med bladvridningsme- kanism.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: WHITEHEAD INSTITUTE FOR BIOMEDICAL